Short communication
Brain kinetics and specific binding of [11C]PK 11195 to ω3 sites in baboons: positron emission tomography study

https://doi.org/10.1016/0014-2999(91)90594-GGet rights and content

Abstract

We characterized, in vivo, using positron emission tomography in baboons, the kinetics and specific binding of i.v. injected [11C]PK 11195 to ω3 sites in the brain. Following immediate access to brain tissue, the brain kinetics of [11C]PK 11195 showed a slow elimination for the 60 min of study. Both coinjection and pulse-chase (at t = 8 min) with saturating amounts of cold PK 11195 immediately enhanced the availability of radiotracer to brain tissue, but also markedly increased the rate of washout. These effects presumably reflect displacement or inhibition of specifically bound [11C]PK 11195 to both peripheral and central ω3 sites, respectively. These results indicate that [11C]PK 11195 has easy access and binds with moderate specificity to the normal primate brain in vivo.

References (10)

There are more references available in the full text version of this article.

Cited by (83)

  • Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs

    2018, Nuclear Medicine and Biology
    Citation Excerpt :

    This finding is in concordance with the scarce uptake found in our study. TSPO receptors in the brain are less abundant than in other parts of the body like the liver and low-level activation is therefore more difficult to detect by PET systems [40,41]. There might be different reasons for the limited [18F]GE180 concentration in the microglia: Low fraction of free radioligand availability to the microglia due to high binding of [18F]GE180 in the endothelial cells in the blood-brain-barrier and venous sinuses [42,43].

  • Imaging in Parkinson's Disease

    2017, International Review of Neurobiology
  • Microglial positron emission tomography (PET) imaging in epilepsy: Applications, opportunities and pitfalls

    2017, Seizure
    Citation Excerpt :

    Despite being the TSPO PET radioligand of choice for two decades, [11C]PK11195 posed significant challenges for quantification (for reviews, see [6,8,10,11]). Firstly, PK11195 is highly lipophilic and shows a high level of non-specific binding (e.g. to brain fat) [27]. By increasing the background non-specific signal, this reduces the signal to noise ratio (Box 2).

  • Imaging brain inflammation in epilepsy

    2014, Neuroscience
    Citation Excerpt :

    In fact, the vast majority of PET imaging studies on TSPO in humans has been performed with this tracer. Nevertheless, several limitations can be attributed to PK11195 including low binding potential, high non-specific binding (Petit-Taboue et al., 1991; Shah et al., 1994) and therefore an unfavourable signal to noise ratio, and problematic quantification or modelling of receptor density (Petit-Taboue et al., 1991; Venneti et al., 2006). Many new TSPO PET ligands have been developed in an attempt to overcome these shortcomings and to improve the quantification of TSPO expression.

  • Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [<sup>18</sup>F]-FEPPA

    2014, NeuroImage
    Citation Excerpt :

    Due to its higher affinity, [18F]-FEPPA may provide greater sensitivity than PK11195 as a TSPO radioligand. The higher affinity of [18F]-FEPPA may overcome the low signal to noise ratio of PK11195, which has been reported in several studies (Banati et al., 2000; Groom et al., 1995; Petit-Taboue et al., 1991). A direct in vivo comparison between [18F]-FEPPA and [11C]-PK11195 in animal model of neuroinflammation revealed that [18F]-FEPPA showed a greater contrast uptake between the lesioned and healthy area.

View all citing articles on Scopus
View full text